FTSE All-Share

FTSE All-Share handeln
5.504,53 PKT -21,74 PKT -0,39 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN 621441

ISIN GB0031758641


Analysen zu FTSE All-Share-Werten

Datum Rating Analyst
28.10.14 Unilever Neutral Goldman Sachs Group Inc.
28.10.14 BP buy S&P Capital IQ
28.10.14 Standard Chartered Hold S&P Capital IQ
28.10.14 GSK Hold Kepler Cheuvreux
28.10.14 London Stock Exchange (LSE) overweight Morgan Stanley
28.10.14 HSBC Hold Deutsche Bank AG
27.10.14 GSK Sell UBS AG
27.10.14 BAT Halten Independent Research GmbH
27.10.14 Rio Tinto Outperform BNP PARIBAS
27.10.14 AstraZeneca buy UBS AG
27.10.14 Lloyds Banking Group Underperform Jefferies & Company Inc.
27.10.14 BP Neutral Goldman Sachs Group Inc.
27.10.14 Shell (ex Royal Dutch Shell) Neutral Goldman Sachs Group Inc.
27.10.14 Lloyds Banking Group buy Deutsche Bank AG
27.10.14 Barclays buy Deutsche Bank AG
24.10.14 Unilever Equal-Weight Morgan Stanley
24.10.14 GSK Sell UBS AG
24.10.14 Unilever Neutral UBS AG
24.10.14 Barclays buy UBS AG
24.10.14 Lloyds Banking Group buy UBS AG
24.10.14 BP Neutral UBS AG
24.10.14 Shell (ex Royal Dutch Shell) buy UBS AG
23.10.14 GSK Sell UBS AG
23.10.14 GSK neutral Independent Research GmbH
23.10.14 Unilever Sell S&P Capital IQ
23.10.14 Unilever verkaufen S&P Capital IQ
23.10.14 GSK overweight Morgan Stanley
23.10.14 Unilever Underweight JP Morgan Chase & Co.
23.10.14 Unilever Underweight JP Morgan Chase & Co.
23.10.14 BAT Equal-Weight Morgan Stanley
23.10.14 London Stock Exchange (LSE) overweight HSBC
23.10.14 GSK Neutral JP Morgan Chase & Co.
23.10.14 BAT overweight JP Morgan Chase & Co.
22.10.14 GSK buy S&P Capital IQ
22.10.14 BAT Hold S&P Capital IQ
22.10.14 Shell (ex Royal Dutch Shell) Outperform Credit Suisse Group
22.10.14 London Stock Exchange (LSE) Neutral UBS AG
22.10.14 BP Neutral Credit Suisse Group
21.10.14 Standard Chartered verkaufen Credit Suisse Group
21.10.14 Standard Chartered overweight JP Morgan Chase & Co.